SCHEDULE: HUB Cyber Security Acquires Evofem Notes & Rights
Schedule 13D Filing
HUB Cyber Security Ltd. has acquired significant convertible notes and purchase rights in Evofem Biosciences, Inc., signaling a strategic investment and potential collaboration.
Summary
- HUB Cyber Security Ltd. (HUB) has acquired Evofem Notes and Purchase Rights from various sellers through private placements.
- These acquisitions represent a strategic investment by HUB into Evofem Biosciences, Inc. (the Issuer).
- HUB acquired Evofem Notes and June Purchase Rights for approximately $49.3 million and July Purchase Rights for $15.2 million, paid for with HUB equity.
- The acquired notes are convertible into Evofem's common stock at $0.0154 per share, and the rights are exercisable at the same price.
- HUB may beneficially own up to 9.99% of Evofem's common stock, subject to limitations.
- HUB also issued a $706,304 subordinated promissory note to Evofem, to be used for supplier payments for PHEXX and SOLOSEC.
- This promissory note includes covenants restricting certain actions by Evofem without HUB's consent.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this filing as having a slightly negative sentiment due to the acquisition of distressed debt and rights, indicating potential financial instability in the target company, Evofem Biosciences, Inc.
Positives
- HUB Cyber Security is making a strategic investment, potentially expanding into the women's health and wellness sector.
- The acquisition was made using HUB's equity, preserving cash for HUB.
- HUB has provided a subordinated promissory note to Evofem to support its operations and supplier payments for key products.
- The promissory note includes covenants that give HUB some control over Evofem's significant corporate actions.
Negatives
- The acquisition involves distressed debt (convertible notes) and purchase rights, suggesting Evofem Biosciences may be in financial distress.
- HUB's potential ownership is capped at 9.99% due to beneficial ownership limitations, indicating a controlled but not controlling stake.
- Evofem Biosciences has disclosed insufficient authorized and unissued common stock to cover full conversion/exercise of its outstanding convertible securities and equity-linked instruments.
Risks
- Evofem Biosciences may not have sufficient authorized shares to allow for full conversion of the acquired notes and exercise of the rights.
- The value of HUB's investment is tied to the performance and financial health of Evofem Biosciences, which appears to be struggling.
- HUB's investment is subject to beneficial ownership limitations, capping its direct influence.
- The subordinated nature of the promissory note means HUB's repayment is secondary to Evofem's senior secured and unsecured convertible notes.
Future Outlook
HUB intends to explore collaboration opportunities with Evofem Biosciences and will continuously review its investment, potentially engaging in discussions with management and other stakeholders regarding the Issuer's business, operations, and strategic direction. HUB may take actions concerning its investment as it deems appropriate, including potential commercial collaborations, financings, refinancings, or restructurings.
Management Comments
- HUB acquired the Evofem Notes and the Purchase Rights for strategic investment purposes, as part of a broader transformation plan intended to strengthen HUB's financial position and expand into the women's health and wellness sector while preserving cash.
- HUB intends to explore opportunities to collaborate with the Issuer.
Industry Context
StockSavvy.ai notes that this filing indicates a trend of cybersecurity firms like HUB Cyber Security diversifying their business models by investing in or acquiring stakes in companies in other sectors, particularly those with potential for restructuring or strategic turnaround. This move into women's health and wellness via distressed debt acquisition is a bold, albeit risky, diversification strategy.
Comparison to Industry Standards
- No direct industry standard comparisons are available for this specific type of transaction (acquisition of distressed debt and rights in a different sector by a cybersecurity firm).
- The structure of the acquisition, using HUB's equity rather than cash, aligns with a strategy to conserve liquidity, a common practice for companies seeking to manage cash flow during periods of investment or expansion.
- The terms of the Evofem Notes and Purchase Rights, including conversion price and beneficial ownership limitations, are typical for such instruments in financially challenged companies, aiming to provide upside potential to investors while mitigating immediate dilution.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Covenants in Promissory Note | The subordinated promissory note issued by Evofem to HUB includes covenants that restrict certain actions by Evofem without HUB's prior written consent. These include mergers or consolidations, sales of substantially all assets, dissolution or bankruptcy filings, amendments to organizational documents, and material changes to the nature of the Issuer's business. | 2026-07-08 | Increases HUB's influence over Evofem's strategic decisions and operational changes, providing a degree of oversight and control despite the subordinated nature of the debt. |
Stakeholder Impact
- Shareholders of HUB Cyber Security Ltd.: The issuance of HUB equity securities as consideration for the acquisitions dilutes existing shareholders. However, it represents a strategic move that could lead to future growth.
- Shareholders of Evofem Biosciences, Inc.: The acquisition of debt and rights by HUB, along with the promissory note and associated covenants, may impact Evofem's operational flexibility and future capital structure. The potential for collaboration could be positive if successful.
- Creditors of Evofem Biosciences, Inc.: The subordinated nature of HUB's promissory note means it ranks below senior debt. The covenants in the note could affect Evofem's ability to meet its obligations to other creditors if not managed carefully.
Next Steps
- HUB will explore opportunities to collaborate with Evofem Biosciences, Inc.
- HUB may engage in discussions with Evofem's management, board of directors, and other stakeholders.
- HUB may make suggestions or proposals concerning Evofem's business, operations, assets, capitalization, financial condition, strategy, governance, and future plans.
- HUB may take actions such as commercial collaborations, financings, refinancings, or restructurings of Evofem's indebtedness.
- HUB will review its investment in Evofem on a continuing basis.
Key Dates
| Date | Description |
|---|---|
| 2022-09-15 | Original issuance of Purchase Rights by Evofem Biosciences, Inc. |
| 2023-12-01 | Restructuring Agreements for Evofem Notes. |
| 2025-04-08 | Issuance of Evofem Notes by Evofem Biosciences, Inc. to Aditxt, Inc. |
| 2025-06-26 | Issuance of Evofem Notes by Evofem Biosciences, Inc. to Aditxt, Inc. |
| 2026-03-31 | Quarter end for Evofem Biosciences, Inc.'s Form 10-Q. |
| 2026-05-11 | Evofem Biosciences, Inc. outstanding shares as of this date. |
| 2026-05-15 | Evofem Biosciences, Inc. filed Form 10-Q for quarter ended March 31, 2026. |
| 2026-06-24 | Closing price of HUB's ordinary shares on Nasdaq. |
| 2026-06-26 | HUB Cyber Security Ltd. entered into securities purchase agreements for Evofem Notes and June Purchase Rights. |
| 2026-06-28 | Expiration date for Evofem Purchase Rights. |
| 2026-06-30 | Closing of the June Private Placement for Evofem Notes and June Purchase Rights. |
| 2026-07-01 | HUB's Form 6-K filing referencing June Purchase Agreement and Pre-funded Warrant. |
| 2026-07-08 | Evofem Biosciences, Inc. issued a subordinated promissory note to HUB Cyber Security Ltd. |
| 2026-07-20 | HUB Cyber Security Ltd. entered into a securities purchase agreement for July Purchase Rights. |
| 2026-07-21 | Closing of the July Private Placement for July Purchase Rights. |
| 2026-08-04 | HUB's Form 6-K filing referencing July Purchase Agreement and Pre-funded Warrant. |
| 2026-12-01 | Maturity date for Exchanged Notes. |
| 2027-06-28 | Expiration date for Evofem Purchase Rights. |
| 2028-04-08 | Maturity date for Evofem Notes issued to Aditxt, Inc. |
| 2028-06-26 | Maturity date for Evofem Notes issued to Aditxt, Inc. |
Recommendation
holdHUB Cyber Security's acquisition of distressed debt and rights in Evofem Biosciences, Inc. presents a complex situation. While the strategic intent and potential for collaboration are noted, the underlying financial weakness of Evofem and the limitations on HUB's ownership stake introduce significant risk. The use of HUB's equity for the acquisition also dilutes existing HUB shareholders. Therefore, a 'hold' recommendation reflects a cautious approach, awaiting further clarity on the success of the strategic investment and potential operational improvements at Evofem.
Keywords
Schedule 13D, HUB Cyber Security, Evofem Biosciences, Convertible Notes, Purchase Rights, Strategic Investment, Promissory Note, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.